These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6272361)

  • 1. [Dopamine receptors (author's transl)].
    Usuda S; Maeno H
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1592-9. PubMed ID: 6272361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synaptic receptors (author's transl)].
    Kuriyama K
    Tanpakushitsu Kakusan Koso; 1977; 22(6):572-9. PubMed ID: 200975
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dopamine receptor].
    Okuda M; Togashi S
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):707-17. PubMed ID: 2159172
    [No Abstract]   [Full Text] [Related]  

  • 4. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 5. [Regulatory effects of the presynaptic receptors on transmitter release (author's transl)].
    Yang K
    Sheng Li Ke Xue Jin Zhan; 1982 Jan; 13(1):43-7. PubMed ID: 6125032
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amine receptors and adenylate cyclase: on the role of GTP binding regulatory protein (author's transl)].
    Haga T
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1637-45. PubMed ID: 6272364
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Piracetam and the activity of alpha- and beta-adrenergic, dopaminergic and muscarine cholinergic receptors (author's transl)].
    Atanacković D; Simonić A
    Lijec Vjesn; 1981 Dec; 103(12):545-9. PubMed ID: 6285100
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of calmodulin in the modulation of dopamine receptor function.
    Hanbauer I; Phyall W
    Adv Biochem Psychopharmacol; 1980; 24():133-8. PubMed ID: 6996439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of chlorpromazine on dopaminergic receptor functions in rat brain--difference of the response of several dopaminergic systems after chronic administration (author's transl)].
    Kaneno S
    Seishin Shinkeigaku Zasshi; 1980 Jun; 82(6):335-52. PubMed ID: 7465695
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine mechanisms in the subthalamic nucleus and possible relationship to hemiballismus and other movement disorders.
    Wolfson L; Brown LL; Makman M; Warner C; Dvorkin B; Katzman R
    Adv Neurol; 1982; 35():203-11. PubMed ID: 7148578
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
    Gnegy ME; Bernabei A; Treisman G
    J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of calmodulin in the regulation of dopamine receptor function.
    Hanbauer I; Memo M; Billingsley M
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():521-7. PubMed ID: 6328934
    [No Abstract]   [Full Text] [Related]  

  • 14. Dopamine receptor system involving adenylate cyclase in canine caudate nucleus.
    Maeno H; Sano K; Nishikori K; Noshiro O; Sato A; Yoneda T; Usuda S; Iwanami S
    Adv Biochem Psychopharmacol; 1983; 36():175-83. PubMed ID: 6344564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
    Cai G; Wang HY; Friedman E
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1105-12. PubMed ID: 12183669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of lisuride, an ergot derivative, with serotonergic and dopaminergic receptors in rabbit brain.
    Rosenfeld MR; Makman MH
    J Pharmacol Exp Ther; 1981 Mar; 216(3):526-31. PubMed ID: 7205633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I; Sibley DR; Leff SE
    Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [[Dopamine receptor; characterization of D-2 receptor in the intermediate lobe of the pituitary gland (author's transl)].
    Munemura M
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1600-8. PubMed ID: 6272362
    [No Abstract]   [Full Text] [Related]  

  • 19. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
    Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
    Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.